vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and DAKTRONICS INC (DAKT). Click either name above to swap in a different company.

DAKTRONICS INC is the larger business by last-quarter revenue ($229.3M vs $121.8M, roughly 1.9× Core Laboratories Inc.). DAKTRONICS INC runs the higher net margin — 7.6% vs 4.2%, a 3.4% gap on every dollar of revenue. On growth, DAKTRONICS INC posted the faster year-over-year revenue change (10.0% vs -1.4%). DAKTRONICS INC produced more free cash flow last quarter ($14.0M vs $517.0K). Over the past eight quarters, DAKTRONICS INC's revenue compounded faster (16.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Daktronics, Inc. is an American company based in Brookings, South Dakota, that designs, manufactures, sells, and services video displays, scoreboards, digital billboards, dynamic message signs, sound systems, and related products. It was founded in 1968 by two South Dakota State University professors.

CLB vs DAKT — Head-to-Head

Bigger by revenue
DAKT
DAKT
1.9× larger
DAKT
$229.3M
$121.8M
CLB
Growing faster (revenue YoY)
DAKT
DAKT
+11.5% gap
DAKT
10.0%
-1.4%
CLB
Higher net margin
DAKT
DAKT
3.4% more per $
DAKT
7.6%
4.2%
CLB
More free cash flow
DAKT
DAKT
$13.5M more FCF
DAKT
$14.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
DAKT
DAKT
Annualised
DAKT
16.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CLB
CLB
DAKT
DAKT
Revenue
$121.8M
$229.3M
Net Profit
$5.1M
$17.5M
Gross Margin
27.0%
Operating Margin
1.5%
9.4%
Net Margin
4.2%
7.6%
Revenue YoY
-1.4%
10.0%
Net Profit YoY
-18.3%
EPS (diluted)
$0.11
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
DAKT
DAKT
Q1 26
$121.8M
Q4 25
$138.3M
$229.3M
Q3 25
$134.5M
$219.0M
Q2 25
$130.2M
$172.6M
Q1 25
$123.6M
$149.5M
Q4 24
$129.2M
$208.3M
Q3 24
$134.4M
$226.1M
Q2 24
$130.6M
$215.9M
Net Profit
CLB
CLB
DAKT
DAKT
Q1 26
$5.1M
Q4 25
$4.9M
$17.5M
Q3 25
$14.2M
$16.5M
Q2 25
$10.6M
$-9.4M
Q1 25
$-154.0K
$-17.2M
Q4 24
$7.4M
$21.4M
Q3 24
$11.7M
$-4.9M
Q2 24
$9.0M
$2.5M
Gross Margin
CLB
CLB
DAKT
DAKT
Q1 26
Q4 25
20.8%
27.0%
Q3 25
22.0%
29.7%
Q2 25
20.3%
25.0%
Q1 25
19.5%
24.6%
Q4 24
17.8%
26.8%
Q3 24
20.5%
26.4%
Q2 24
21.2%
25.7%
Operating Margin
CLB
CLB
DAKT
DAKT
Q1 26
1.5%
Q4 25
11.5%
9.4%
Q3 25
15.6%
10.6%
Q2 25
11.7%
-1.0%
Q1 25
3.6%
-2.4%
Q4 24
11.0%
7.6%
Q3 24
14.7%
10.0%
Q2 24
12.3%
9.0%
Net Margin
CLB
CLB
DAKT
DAKT
Q1 26
4.2%
Q4 25
3.6%
7.6%
Q3 25
10.6%
7.5%
Q2 25
8.2%
-5.5%
Q1 25
-0.1%
-11.5%
Q4 24
5.7%
10.3%
Q3 24
8.7%
-2.2%
Q2 24
6.9%
1.2%
EPS (diluted)
CLB
CLB
DAKT
DAKT
Q1 26
$0.11
Q4 25
$0.11
$0.35
Q3 25
$0.30
$0.33
Q2 25
$0.22
$0.04
Q1 25
$0.00
$-0.36
Q4 24
$0.15
$0.22
Q3 24
$0.25
$-0.11
Q2 24
$0.19
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
DAKT
DAKT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$149.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$297.5M
Total Assets
$587.7M
$548.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
DAKT
DAKT
Q1 26
$22.8M
Q4 25
$22.7M
$149.6M
Q3 25
$25.6M
$136.9M
Q2 25
$31.2M
$127.5M
Q1 25
$22.1M
$132.2M
Q4 24
$19.2M
$134.4M
Q3 24
$21.5M
$96.8M
Q2 24
$17.7M
$81.3M
Total Debt
CLB
CLB
DAKT
DAKT
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
DAKT
DAKT
Q1 26
$275.1M
Q4 25
$266.0M
$297.5M
Q3 25
$271.3M
$279.8M
Q2 25
$261.3M
$271.9M
Q1 25
$253.4M
$272.3M
Q4 24
$246.6M
$260.9M
Q3 24
$250.7M
$238.2M
Q2 24
$240.3M
$238.8M
Total Assets
CLB
CLB
DAKT
DAKT
Q1 26
$587.7M
Q4 25
$584.0M
$548.4M
Q3 25
$591.4M
$545.6M
Q2 25
$602.1M
$502.9M
Q1 25
$591.5M
$524.2M
Q4 24
$585.1M
$551.9M
Q3 24
$600.5M
$553.9M
Q2 24
$597.8M
$527.9M
Debt / Equity
CLB
CLB
DAKT
DAKT
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
DAKT
DAKT
Operating Cash FlowLast quarter
$4.0M
$16.5M
Free Cash FlowOCF − Capex
$517.0K
$14.0M
FCF MarginFCF / Revenue
0.4%
6.1%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
0.77×
0.94×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$61.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
DAKT
DAKT
Q1 26
$4.0M
Q4 25
$7.9M
$16.5M
Q3 25
$8.5M
$26.1M
Q2 25
$13.9M
$22.9M
Q1 25
$6.7M
$12.0M
Q4 24
$20.6M
$43.3M
Q3 24
$13.1M
$19.5M
Q2 24
$17.1M
$9.5M
Free Cash Flow
CLB
CLB
DAKT
DAKT
Q1 26
$517.0K
Q4 25
$5.0M
$14.0M
Q3 25
$6.5M
$21.8M
Q2 25
$10.4M
$18.0M
Q1 25
$3.9M
$7.8M
Q4 24
$17.4M
$38.0M
Q3 24
$10.4M
$14.4M
Q2 24
$14.3M
$6.1M
FCF Margin
CLB
CLB
DAKT
DAKT
Q1 26
0.4%
Q4 25
3.6%
6.1%
Q3 25
4.8%
10.0%
Q2 25
8.0%
10.5%
Q1 25
3.1%
5.2%
Q4 24
13.4%
18.2%
Q3 24
7.7%
6.4%
Q2 24
10.9%
2.8%
Capex Intensity
CLB
CLB
DAKT
DAKT
Q1 26
Q4 25
2.1%
1.1%
Q3 25
1.5%
2.0%
Q2 25
2.7%
2.8%
Q1 25
2.3%
2.8%
Q4 24
2.5%
2.6%
Q3 24
2.0%
2.2%
Q2 24
2.2%
1.6%
Cash Conversion
CLB
CLB
DAKT
DAKT
Q1 26
0.77×
Q4 25
1.61×
0.94×
Q3 25
0.60×
1.58×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
2.02×
Q3 24
1.12×
Q2 24
1.90×
3.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

DAKT
DAKT

Live Events Segment$81.5M36%
Transferred At Point In Time$41.9M18%
Limited Configuration$39.2M17%
Other$30.6M13%
Transportation Segment$21.3M9%
Transferred Over Time$8.8M4%
Unique Configuration$6.0M3%

Related Comparisons